NYSEAMERICAN : CATX
Perspective Therapeutics, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 1.15 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 131.27M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Perspective Therapeutics, Inc. (CATX) reported revenue of 409.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 409.00K | 884.00K | 1.45M | 1.43M | 5.42M | |
| Cost of Revenue | 96.18M | 84.22M | 41.64M | 20.34M | 3.05M | |
| Gross Profit | -95.77M | -83.33M | -40.18M | -18.91M | 2.37M | |
| Selling, General & Admin | 29.46M | 30.23M | 26.61M | 21.06M | 9.35M | 5.57M |
| Research & Development | 968.00K | 1.81M | 850.00K | |||
| Operating Expenses | 29.46M | 30.23M | 26.61M | 22.03M | 11.16M | 6.42M |
| Operating Income | -125.23M | -113.56M | -66.80M | -40.94M | -8.80M | -6.42M |
| Interest Expense | -305.00K | -376.00K | -48.00K | -82.00K | ||
| Interest & Investment Income | 8.12M | 8.11M | 10.52M | 934.00K | 618.00K | 119.00K |
| Earnings From Equity Investments | -2.00K | -2.00K | -8.00K | -17.00K | ||
| Other Non Operating Income (Expenses) | 1.40M | |||||
| EBT Excluding Unusual Items | -117.42M | -104.43M | -56.34M | -40.11M | -8.18M | -6.30M |
| Impairment of Goodwill | -24.06M | |||||
| Gain (Loss) on Sale of Assets | -27.00K | -305.00K | ||||
| Pretax Income | -117.42M | -104.43M | -80.43M | -40.11M | -8.48M | -6.30M |
| Income Tax Expense | -793.00K | -793.00K | -2.10M | -2.65M | ||
| Earnings From Continuing Operations | -116.63M | -103.64M | -78.33M | -37.45M | -8.48M | -6.30M |
| Earnings From Discontinued Operations | 197.00K | 514.00K | -949.00K | -9.05M | -2.27M | -972.00K |
| Net Income | -116.43M | -103.12M | -79.28M | -46.51M | -10.76M | -7.27M |
| Net Income to Common | -116.43M | -103.12M | -79.28M | -46.51M | -10.76M | -7.27M |
| Shares Outstanding (Basic) | 93.25M | 73.81M | 64.42M | 26.76M | 14.21M | 14.20M |
| Shares Outstanding (Diluted) | 93.25M | 73.81M | 64.42M | 26.76M | 14.21M | 14.20M |
| EPS (Basic) | -1.25 | -1.40 | -1.23 | -1.74 | -0.76 | -0.51 |
| EPS (Diluted) | -1.25 | -1.40 | -1.23 | -1.74 | -0.76 | -0.51 |
| Free Cash Flow | -121.19M | -95.23M | -72.71M | -37.98M | -10.68M | -7.98M |
| Free Cash Flow Per Share | -1.30 | -1.29 | -1.13 | -1.42 | -0.75 | -0.56 |
| Gross Margin | 43.71% | |||||
| Operating Margin | -30,619.07% | -12,846.61% | -4,594.02% | -2,855.02% | -162.47% | |
| Profit Margin | -28,467.97% | -11,665.27% | -5,452.48% | -3,243.24% | -198.71% | |
| Free Cash Flow Margin | -29,630.07% | -10,772.96% | -5,000.55% | -2,648.88% | -197.28% | |
| EBITDA | -121.19M | -110.32M | -64.50M | -40.23M | -8.48M | -6.14M |
| EBITDA Margin | -156.56% | |||||
| D&A For EBITDA | 4.05M | 3.24M | 2.30M | 714.00K | 320.00K | 280.00K |
| EBIT | -125.23M | -113.56M | -66.80M | -40.94M | -8.80M | -6.42M |
| EBIT Margin | -162.47% | |||||
| Revenue as Reported | 5.42M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 48.49M | 30.63M | 61.58M | 9.24M | 20.99M | 55.89M |
| Short-Term Investments | 188.39M | 114.11M | 165.34M | 22.76M | ||
| Cash & Short-Term Investments | 236.88M | 144.74M | 226.92M | 9.24M | 43.76M | 55.89M |
| Accounts Receivable | 269.00K | 6.00K | 116.00K | 1.17M | 1.36M | 1.61M |
| Other Receivables | 1.03M | 1.37M | 10.00K | 2.00K | 17.00K | |
| Receivables | 269.00K | 1.04M | 1.48M | 1.18M | 7.47M | 1.62M |
| Inventory | 1.40M | |||||
| Prepaid Expenses | 4.38M | 2.58M | 2.68M | 1.08M | 441.00K | 391.00K |
| Other Current Assets | 35.00K | 81.00K | 5.35M | 1.54M | 27.00K | |
| Total Current Assets | 241.52M | 148.39M | 231.16M | 16.84M | 53.22M | 59.33M |
| Property, Plant & Equipment | 109.99M | 78.10M | 59.54M | 6.32M | 371.00K | 2.49M |
| Long-Term Investments | 124.00K | 126.00K | 133.00K | 150.00K | ||
| Goodwill | 24.06M | |||||
| Other Intangible Assets | 40.00M | 40.00M | 50.01M | 50.35M | 25.00K | 107.00K |
| Other Long-Term Assets | 509.00K | 358.00K | 268.00K | 182.00K | 4.33M | 2.52M |
| Total Assets | 392.02M | 266.97M | 341.10M | 97.89M | 58.09M | 64.44M |
| Accounts Payable | 29.22M | 20.31M | 9.84M | 6.41M | 1.54M | 966.00K |
| Accrued Expenses | 5.97M | 7.49M | 5.48M | 3.59M | 1.30M | 1.03M |
| Current Portion of Long-Term Debt | 57.00K | 56.00K | 52.00K | 49.00K | ||
| Current Portion of Leases | 1.10M | 623.00K | 957.00K | 46.00K | 268.00K | |
| Current Unearned Revenue | 1.40M | |||||
| Other Current Liabilities | 200.00K | 200.00K | 500.00K | 5.57M | 276.00K | |
| Total Current Liabilities | 36.54M | 28.68M | 18.23M | 15.66M | 3.12M | 2.27M |
| Long-Term Debt | 1.54M | 1.57M | 1.62M | 1.68M | ||
| Long-Term Leases | 1.27M | 1.00M | 1.43M | 780.00K | 256.00K | |
| Long-Term Unearned Revenue | 26.60M | 26.60M | 26.60M | |||
| Long-Term Deferred Tax Liabilities | 1.70M | 1.70M | 2.50M | 4.59M | ||
| Other Long-Term Liabilities | 507.00K | 386.00K | 55.00K | 331.00K | 640.00K | |
| Total Liabilities | 68.16M | 59.94M | 50.43M | 22.71M | 3.45M | 3.16M |
| Common Stock | 114.00K | 74.00K | 70.00K | 28.00K | 142.00K | 142.00K |
| Additional Paid-In Capital | 711.78M | 541.69M | 522.37M | 227.59M | 160.43M | 159.73M |
| Retained Earnings | -387.81M | -334.84M | -231.72M | -152.44M | -105.93M | -98.60M |
| Comprehensive Income & Other | -221.00K | 110.00K | -51.00K | |||
| Shareholders' Equity | 323.86M | 207.03M | 290.67M | 75.18M | 54.64M | 61.28M |
| Total Liabilities & Equity | 392.02M | 266.97M | 341.10M | 97.89M | 58.09M | 64.44M |
| Total Debt | 3.96M | 3.25M | 4.06M | 2.55M | 524.00K | |
| Net Cash (Debt) | 232.91M | 141.48M | 222.85M | 6.69M | 43.76M | 55.37M |
| Net Cash Per Share | 2.50 | 1.92 | 3.46 | 0.25 | 3.08 | 3.90 |
| Filing Date Shares Outstanding | 114.15M | 113.93M | 74.05M | 58.69M | 28.00M | 14.21M |
| Total Common Shares Outstanding | 114.09M | 74.34M | 70.67M | 28.18M | 14.21M | 14.20M |
| Working Capital | 204.98M | 119.71M | 212.93M | 1.17M | 50.10M | 57.06M |
| Book Value Per Share | 2.84 | 2.78 | 4.11 | 2.67 | 3.84 | 4.31 |
| Tangible Book Value | 283.86M | 167.03M | 240.66M | 763.00K | 54.62M | 61.17M |
| Tangible Book Value Per Share | 2.49 | 2.25 | 3.41 | 0.03 | 3.84 | 4.31 |
| Land | 917.00K | 917.00K | 917.00K | 1.28M | 366.00K | 366.00K |
| Buildings | 1.77M | 1.77M | 1.77M | 1.77M | ||
| Machinery | 16.34M | 15.46M | 11.42M | 2.68M | 18.00K | 4.44M |
| Construction In Progress | 93.34M | 60.79M | 42.60M | |||
| Leasehold Improvements | 3.90M | 3.86M | 3.57M | 179.00K | 4.14M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -116.43M | -103.12M | -79.28M | -46.51M | -10.76M | -7.27M |
| Depreciation & Amortization | 4.05M | 3.24M | 2.30M | 714.00K | 320.00K | 280.00K |
| Other Amortization | 7.00K | 7.00K | 7.00K | 7.00K | 4.00K | 7.00K |
| Loss (Gain) From Sale of Assets | 27.00K | 22.00K | 305.00K | |||
| Asset Writedown & Restructuring Costs | 24.06M | |||||
| Loss (Gain) From Sale of Investments | -2.11M | -2.72M | -607.00K | |||
| Stock-Based Compensation | 10.06M | 8.97M | 5.22M | 3.14M | 983.00K | 1.09M |
| Other Operating Activities | 9.35M | 9.46M | -2.06M | -2.24M | -220.00K | 4.00K |
| Change in Accounts Receivable | -44.00K | 110.00K | 1.05M | 198.00K | 284.00K | 405.00K |
| Change in Inventory | -2.00M | -2.67M | ||||
| Change in Accounts Payable | 1.11M | 147.00K | 1.89M | 1.57M | 690.00K | 236.00K |
| Change in Unearned Revenue | -1.40M | 28.00M | ||||
| Change in Other Net Operating Assets | 935.00K | 2.82M | 864.00K | 790.00K | -28.00K | 182.00K |
| Operating Cash Flow | -93.07M | -82.48M | -18.29M | -36.91M | -10.40M | -7.71M |
| Capital Expenditures | -28.12M | -12.75M | -54.41M | -1.07M | -282.00K | -266.00K |
| Sale of Property, Plant & Equipment | 335.00K | |||||
| Cash Acquisitions | 2.70M | |||||
| Investment in Securities | -23.77M | 54.11M | -164.78M | 22.76M | -22.69M | |
| Other Investing Activities | -111.00K | -135.00K | -72.00K | -18.00K | -6.02M | -18.00K |
| Investing Cash Flow | -52.01M | 41.23M | -218.93M | 24.37M | -28.99M | -284.00K |
| Long-Term Debt Repaid | -52.00K | -48.00K | -68.00K | |||
| Net Debt Issued (Repaid) | -54.00K | -52.00K | -48.00K | -68.00K | ||
| Issuance of Common Stock | 164.76M | 10.36M | 289.43M | 918.00K | 28.00K | 56.00K |
| Other Financing Activities | -65.00K | |||||
| Financing Cash Flow | 164.71M | 10.30M | 289.38M | 785.00K | 28.00K | 56.00K |
| Net Cash Flow | 19.64M | -30.95M | 52.16M | -11.76M | -39.36M | -7.94M |
| Free Cash Flow | -121.19M | -95.23M | -72.71M | -37.98M | -10.68M | -7.98M |
| Free Cash Flow Margin | -29,630.07% | -10,772.96% | -5,000.55% | -2,648.88% | -197.28% | |
| Free Cash Flow Per Share | -1.30 | -1.29 | -1.13 | -1.42 | -0.75 | -0.56 |
| Levered Free Cash Flow | -69.43M | -60.37M | -83.66M | -8.54M | -2.73M | |
| Unlevered Free Cash Flow | -69.23M | -60.14M | -83.63M | -8.49M | -2.73M | |
| Change in Working Capital | 2.00M | 1.68M | 31.80M | 2.56M | -1.05M | -1.85M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 126.71M | 204.43M | 215.60M | 112.79M | 35.12M | 43.89M |
| Enterprise Value | -106.20M | 33.61M | -47.97M | 98.11M | -18.54M | -14.43M |
| Last Close Price | 1.15 | 2.75 | 3.19 | 4.02 | 2.47 | 3.09 |
| Forward PE | 21.50 | 21.50 | 21.50 | 21.50 | 21.50 | |
| PS Ratio | 302.82 | 231.25 | 148.28 | 78.65 | 6.49 | |
| PB Ratio | 0.41 | 0.99 | 0.74 | 1.50 | 0.64 | 0.72 |
| P/TBV Ratio | 0.44 | 1.22 | 0.90 | 147.82 | 0.64 | 0.72 |
| EV/Sales Ratio | 38.02 | 68.42 | ||||
| Debt / Equity Ratio | 0.01 | 0.02 | 0.01 | 0.03 | 0.01 | |
| Net Debt / Equity Ratio | -0.72 | -0.68 | -0.77 | -0.09 | -0.80 | -0.90 |
| Net Debt / EBITDA Ratio | 1.92 | 1.28 | 3.46 | 0.17 | 5.16 | 9.02 |
| Net Debt / FCF Ratio | 1.92 | 1.49 | 3.06 | 0.18 | 4.10 | 6.94 |
| Asset Turnover | 0.00 | 0.00 | 0.01 | 0.02 | ||
| Quick Ratio | 6.49 | 5.08 | 12.53 | 0.67 | 14.47 | 25.38 |
| Current Ratio | 6.61 | 5.17 | 12.68 | 1.07 | 17.07 | 26.18 |
| Return on Equity (ROE) | -39.57% | -41.65% | -42.82% | -57.70% | -9.79% | |
| Return on Assets (ROA) | -22.27% | -23.34% | -19.02% | -32.81% | -5.95% | |
| Return on Capital Employed (ROCE) | -35.20% | -47.70% | -20.70% | -49.80% | -16.00% | -10.30% |
| Earnings Yield | -112.49% | -50.44% | -36.77% | -41.23% | -30.64% | -16.57% |
| FCF Yield | -97.85% | -46.59% | -33.72% | -33.68% | -30.42% | -18.17% |
| Buyback Yield / Dilution | -29.45% | -14.57% | -140.72% | -88.38% | -0.06% | -36.73% |